[Fecal microbiota transplantation in recurrent Clostridium difficile infections. Framework and pharmaceutical preparation aspects]
- PMID: 25825054
- DOI: 10.1016/j.pharma.2015.02.004
[Fecal microbiota transplantation in recurrent Clostridium difficile infections. Framework and pharmaceutical preparation aspects]
Abstract
The fecal microbiota transplantation consists in introducing a preparation constituted by a dilution of stools of a healthy donor in the digestive tract of a patient recipient, to restore his intestinal physiological balance. This therapeutic approach was the subject of numerous studies showing its efficiency in the treatment of the recurrent infections with Clostridium difficile. The fecal microbiota transplantation has now a high level of clinical evidence, which explains that it appears in various international recommendations. In France, the fecal microbiota transplantation responds to the definition of a medication and can be executed as a pharmaceutical preparation or as an experimental drug for clinical trials under the responsibility of a hospital pharmacy. The objective of this paper is to propose a definition of a framework and to describe the methods of preparation of the fecal microbiota transplantation in the treatment of the recurrent infections with C. difficile and the interactions to consider for hospital pharmacies that do not have technical means to operate this technique.
Keywords: Clostridium difficile infection; Fecal microbiota transplantation; Flora transplantation; Infection à Clostridium difficile; Medication; Médicament; Transfert de flore; Transfert de microbiote fécal.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Faecal microbiota transplantation: Key points to consider.Ann Pharm Fr. 2015 May;73(3):163-8. doi: 10.1016/j.pharma.2015.02.001. Epub 2015 Mar 4. Ann Pharm Fr. 2015. PMID: 25747146 Review.
-
Faecal microbiota transplantation in recurrent Clostridium difficile infection: Recommendations from the French Group of Faecal microbiota Transplantation.Dig Liver Dis. 2016 Mar;48(3):242-7. doi: 10.1016/j.dld.2015.08.017. Epub 2015 Sep 7. Dig Liver Dis. 2016. PMID: 26433619
-
Fecal microbiota transplantation in recurrent Clostridium difficile infection in a patient with concomitant inflammatory bowel disease.Rev Esp Enferm Dig. 2017 Jun;109(6):473-476. doi: 10.17235/reed.2017.4819/2016. Rev Esp Enferm Dig. 2017. PMID: 28506071
-
[Faecal microbiota transplantation in France: what applicable law?].Ann Pharm Fr. 2014 Sep;72(5):363-74. doi: 10.1016/j.pharma.2014.04.003. Epub 2014 Jun 5. Ann Pharm Fr. 2014. PMID: 25220232 French.
-
Fecal Microbiota Transplant: Treatment Options for Clostridium difficile Infection in the Intensive Care Unit.J Intensive Care Med. 2016 Oct;31(9):577-86. doi: 10.1177/0885066615594344. Epub 2015 Jul 3. J Intensive Care Med. 2016. PMID: 26141116 Review.
Cited by
-
Use of frozen native feces for fecal microbiota transplantation in recurrent Clostridioides difficile infection: a simple way to improve the efficiency of donor feces preparation.Antimicrob Agents Chemother. 2024 Oct 8;68(10):e0073424. doi: 10.1128/aac.00734-24. Epub 2024 Aug 21. Antimicrob Agents Chemother. 2024. PMID: 39166867 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical